SOLACI PERIPHERAL | 3rd Clinical Case: Femoral PCI

angioplastia femoral

In keeping with its Clinical Case Discussion Program, SOLACI’s peripheral interventions department, SOLACI Peripheral, presents the third clinical case, to promote knowledge exchange across the entire Latin American hemodynamics community. 

Share your thoughts on case and resolution in the comments and answer the questions at the end of the article.


Femoral PCI


Authors: MD Mauricio Cavalieri Machado / MD Caiser T. S. Junior / MD Thiago José de Assis

Contact: mcavmachado@gmail.com

Healthcare centerLuxemburgo Hospital, Belo Horizonte/ MG. Brazil.


– Patient: 75-year-old woman. Stenting of right and left femoral arteries in 2018.

– Patient informs intermittent claudication after 100 m walk is back, with pain in lower right and left limbs (Fontaine IIB, Rutherford 4).

– History of hypertension, hypothyroidism, dyslipidemia, and atrial fibrillation. Use of losartan 50 mg BID, amlodipine 10 mg MID, simvastatin 40 mg MID, Hidantal, rivaroxaban 20 mg MID, amiodarone, Puran t4 75 mcg/day, fluoxetine 20 mg/day.

– Lower limb echo-doppler shows new occlusions in both femoral arteries. Distal bed is good.

These are the angiography images. TASC D occlusions.

Left lower limb

Right lower limb

Question… What course of action should we recommend?

Case Solution

– We treated both lower limbs percutaneously. We stopped using rivaroxaban and started ASA and clopidogrel 48hrs before procedure.

– To treat the left SFA, we performed a contralateral retrograde right CFA puncture and placed a 6F sheath, 45 cm long. We attempted crossing proximal occlusion into stent lumen, but the guidewire would go to false lumen.

– We then opted for distal SFA approach, with a 4F inductor and retrograde puncture through the thigh.

– We crossed the occlusion and exteriorized the guidewire

– We performed balloon dilation and successfully completed with drug coated balloon.

– One month after first intervention, we treated the right SFA.

– We now puncture the left CFA using contralateral femoral sheath placement. We successfully penetrated proximal stent occlusion but when exiting, there was vessel dissection and the guidewire stayed in false lumen, which prevented advancing along the popliteal.

12- Guidewire in popliteal false lumen

– Once more we opted for the retrograde approach in leg. This time punctured the anterior tibial artery (images 13, 14), advanced the 0,014 guidewire in a retrograde fashion, and exteriorized it (video 2).

– Guidewire snaring.

– Balloon dilation successfully completed with drug coated balloon (images 15,16).

Devices used:

  • 6F Sheath
  • 4F Sheath
  • 0,035 260 cm stiff hydrophilic guidewires
  • IM catheter
  • Long sheath 50 cm Destination
  • Oceanus 35 4 X 80 and 5 X 150 balloon
  • 3,5 X 60 OTW balloon
  • Admiral 6 X 150 cm paclitaxel coated balloon
  • 0,014 PT2 300 cm guidewire
  • 5F Glidecath catheter

Question: what measurements would you use to prevent repeat stent thrombosis?


Conclusions

  • Endovascular treatment can be used in TASC A to D lesions
  • The most popular bailout technique for challenging rechannelization is the retrograde approach which, in addition to good outcomes, has excellent cost-benefit ratio.
  • Drug coated balloons can be used for stent restenosis.

Discover other SOLACI Peripheral clinical cases

 


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Transcatheter Pulmonary Valve Implantation with a Self-Expanding Valve: Outcomes at 3 Years

Pulmonary regurgitation (PR) is a common condition in patients who have undergone surgical repair of Tetralogy of Fallot or other pathologies involving the right...

How to apply for the SOLACI Research 2025 Grant? Step-by-step explanation video

You can now rewatch the virtual event we held on April 9th, where we thoroughly reviewed the steps to apply for the SOLACI Research...

RACE Trial: Effect of Balloon Pulmonary Angioplasty and Riociguat on Right Ventricular Afterload and Function in Chronic Thromboembolic Pulmonary Hypertension

Even though pulmonary endarterectomy is the treatment of choice for chronic thromboembolic pulmonary hypertension (CTEPH), up to 40% of patients are not candidates because...

April 9 – How to Apply for the SOLACI Research Grant 2025? Virtual Zoom Event

The Latin American Society of Interventional Cardiology invites you to a new virtual event hosted by the SOLACI Research Department, aimed at clarifying doubts,...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Pretreatment with DAPT in Acute Coronary Syndrome: An Ongoing Debate?

In acute coronary syndrome (ACS) dual antiplatelet therapy (DAPT) has become a fundamental pillar after percutaneous coronary intervention (PCI), preventing stent thrombosis and acute...

Measuring Post-TAVI Gradients and Their Implications: Are Invasive and Echocardiographic Assessments Comparable?

Transcatheter aortic valve implantation (TAVI) is considered the treatment of choice for a significant proportion of patients with symptomatic aortic stenosis. Outcomes have improved...

Another Blow for Intra-Aortic Balloon Pumo Counterpulsation? Randomized Study on Its Use in Chronic Heart Failure Progressing to Cardiogenic Shock

Cardiogenic shock (CS) remains a condition with extremely high mortality (around 50%). While most therapies for this pathology have been studied in CS secondary...